- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3185EUR$3,500USD£2,731GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2021
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2503EUR$2,750USD£2,146GBP
The Enterovirus Diagnostic market is a subset of the larger Infectious Disease Testing market. It is focused on the diagnosis of enteroviruses, which are a group of viruses that cause a wide range of illnesses, including the common cold, meningitis, and polio. Diagnostic tests for enteroviruses are used to detect the presence of the virus in a patient's sample, such as a blood or tissue sample. These tests are used to diagnose and monitor the progression of the virus, as well as to determine the best course of treatment.
The Enterovirus Diagnostic market is highly competitive, with a number of companies offering a variety of tests. These include Abbott Laboratories, Bio-Rad Laboratories, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more